|
|
Other links at Articles > Allergy and Clinical Immunology |
| 4. |
New Anti-IL-5 Agent Cuts Need for Prednisone in Hypereosinophilic Syndrome
|
|
|
The investigational anti-interleukin-5 (anti-IL-5) monoclonal antibody mepolizumab (GlaxoSmithKline) caused a sharp drop in blood eosinophil count in nearly every patient with hypereosinophilic syndrome who received it. Mepolizumab also reduced the need for corticosteroids. Reuters Health Information
|
| 5. |
Glioma Risk Decreased in Allergic Patients
|
|
|
Patients with allergic conditions have a decreased risk of glioma, according to a report in the October 15th issue of the American Journal of Epidemiology. Reuters Health Information
|
|
|